+ Watch CO
on My Watchlist
The company operates as a cord blood bank in China, providing laboratory testing, cord blood collection, stem cell storage services, and hematopoietic stem cell processing.
Cash flow has gone from negative to positive this year.
Insider ownership is almost 63%. That's good evidence to me that cash flow won't be going negative again any time soon.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions